恒瑞医药：关于药物纳入拟突破性治疗品种公示名单的公告

Group 1 - The core point of the article is that Heng Rui Medicine announced that its subsidiary, Fujian Shengdi Pharmaceutical Co., Ltd., has had its HRS-5635 injection included in the list of proposed breakthrough therapies by the National Medical Products Administration [2] Group 2 - The announcement was made on the evening of September 17, and the public notice period for this inclusion is set for 7 days [2]